Evidence map›Paper›PMID 31186447›Full record

ArticleScientific reports2019

A Versatile, Portable Intravital Microscopy Platform for Studying Beta-cell Biology In Vivo.

Christopher A Reissaus, Annie R Piñeros, Ashley N Twigg, Kara S Orr, Abass M Conteh, Michelle M Martinez, Malgorzata M Kamocka, Richard N Day, Sarah A Tersey, Raghavendra G Mirmira and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. IFN-α Induces Heterogenous ROS Production in Human β-Cells.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Imaging immunometabolismImmunometabolism (Cobham, Surrey) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Christopher A ReissausDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Annie R PiñerosDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Ashley N TwiggHerman B Wells Center for Pediatric Research, Indianapolis, IN, USA.
Kara S OrrDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Abass M ContehDepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Michelle M MartinezDepartment of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA.
Malgorzata M KamockaDepartment of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA.
Richard N DayThe Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Sarah A TerseyDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0003-0667-2361
Raghavendra G MirmiraDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-5013-6075
Kenneth W DunnThe Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
Amelia K LinnemannDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA. aklinnem@iu.edu.ORCID http://orcid.org/0000-0001-7356-4876
Indiana University School of MedicineIndiana University Health · USIndiana University – Purdue University Indianapolis · US

Funding

Translation CoreP30DK097512 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Carmella Evans-Molina · 2015 to 2026
$17.4M
PROBE DELIVERY COREP30DK079312 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DAGHER, PIERRE C · 2007 to 2021
$17.1M
Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN).U24DK104162 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI John S. Kaddis, Joyce Carol Niland · 2019 to 2026
$12.3M
Transcriptional Mechanisms Governing Beta Cell DifferentiationR01DK060581 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Raghavendra G Mirmira · 2002 to 2026
$8.5M
Human Islet Research Network (HIRN) Coordinating CenterU01DK104162 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2014 to 2018
$6.1M
Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
Validation of small molecule 12-lipoxygenase inhibitors in metabolic diseaseR01DK105588 · NIDDK · UNIVERSITY OF CHICAGO · PI KULKARNI, ROHIT N., MIRMIRA, RAGHAVENDRA G · 2015 to 2024
$5.5M
RESEARCH TRAINING PROGRAM IN DIABETES AND OBESITYT32DK064466 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Carmella Evans-Molina, RONALD C WEK · 2003 to 2026
$5.2M
Obesity induced cytokines and beta cell mass regulationK01DK102492 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI LINNEMANN, AMELIA K · 2015 to 2018
$571k
Mechanisms of IL-6 Signaling in Beta-cell Stress ResponseR03DK115990 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI LINNEMANN, AMELIA K · 2018 to 2019
$236k
NIDDK NIH HHS K01 DK102492NIDDK NIH HHS P30 DK079312NIDDK NIH HHS P30 DK097512NIDDK NIH HHS R01 DK060581NIDDK NIH HHS R01 DK105588NIDDK NIH HHS R03 DK115990NIDDK NIH HHS T32 DK064466NIDDK NIH HHS U01 DK104162NIDDK NIH HHS U24 DK104162NIGMS NIH HHS T32 GM077229U.S. Department of Health & Human Services | National Institutes of Health (NIH) T32 KD0604466
6 · The paper itself

Abstract

The pancreatic islet is a complex micro-organ containing numerous cell types, including endocrine, immune, and endothelial cells. The communication of these systems is lost upon isolation of the islets, and therefore the pathogenesis of diabetes can only be fully understood by studying this organized, multicellular environment in vivo. We have developed several adaptable tools to create a versatile platform to interrogate β-cell function in vivo. Specifically, we developed β-cell-selective virally-encoded fluorescent protein biosensors that can be rapidly and easily introduced into any mouse. We then coupled the use of these biosensors with intravital microscopy, a powerful tool that can be used to collect cellular and subcellular data from living tissues. Together, these approaches allowed the observation of in vivo β-cell-specific ROS dynamics using the Grx1-roGFP2 biosensor and calcium signaling using the GcAMP6s biosensor. Next, we utilized abdominal imaging windows (AIW) to extend our in vivo observations beyond single-point terminal measurements to collect longitudinal physiological and biosensor data through repeated imaging of the same mice over time. This platform represents a significant advancement in our ability to study β-cell structure and signaling in vivo, and its portability for use in virtually any mouse model will enable meaningful studies of β-cell physiology in the endogenous islet niche.

Indexed as

AnimalsBiosensing TechniquesCalcium SignalingDisease Models, AnimalEndothelial CellsHumansInsulin-Secreting CellsIntravital MicroscopyIslets of LangerhansIslets of Langerhans TransplantationMice

Identifiers

PMID31186447
PMCPMC6559992
OpenAlexW2952797006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.